- Global Pharma News & Resources

Global Postpartum Depression Treatment Market Research Report to 2027 - Rising Research Activities for Treatment of Postpartum Depression Treatment in Emerging Markets Presents Opportunities -

DUBLIN--(BUSINESS WIRE)--The "Postpartum Depression Treatment Market Research Report by Treatment Type (Antidepressant Drugs and Psychotherapy), Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Postpartum Depression Treatment Market size was estimated at USD 811.23 million in 2021, USD 876.69 million in 2022, and is projected to grow at a CAGR 8.32% to reach USD 1,310.73 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Postpartum Depression Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Postpartum Depression Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Postpartum Depression Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Postpartum Depression Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Postpartum Depression Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Postpartum Depression Treatment Market?

6. What is the market share of the leading vendors in the Global Postpartum Depression Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Postpartum Depression Treatment Market?

Market Dynamics


  • Rising Prevalences of Mood Disorder Associated with Pregnancy Across the Globe
  • Growing Demand for Antidepressant Medication and Talk Therapies
  • Increasing Approvals from Regulatory Bodies for Ppd Treatment


  • Limited Awareness About the Postpartum Depression Treatment


  • Development of the Drug by Pharmaceutical Companies and Their Approvals Targeting the Postpartum Depression
  • Rising Research Activities for Treatment of Postpartum Depression Treatment (Ppd) in Emerging Markets


  • Focus on Non-Medication Treatments Such as Psychotherapy, Yoga, and Exercise

Companies Mentioned

  • Accord Healthcare Ltd.
  • Alvogen Group Inc
  • Anikem Laboratories
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Cipla Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Intas Pharmaceuticals Ltd.
  • Lupin Ltd.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sage Therapeutics, Inc.
  • Sebela Pharmaceuticals, Inc.
  • Shionogi & Company, Limited
  • Solvay S.A.
  • Sumika Polymer Compounds (EU) Ltd
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceuticals Industries Ltd.

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 12-Sep-2022